Overview
A long-term follow-up of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.
Eligibility
Inclusion Criteria:
- Subjects who completed study obligations of the CLTD5759 CI-DEX study and enrolled at a site selected for participation.
- Subjects implanted with a CI632D or a CI632 cochlear implant under the CLTD5759 (NCT04750642).
- Willing and able to provide written informed consent.
Exclusion Criteria:
- Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to participation as determined by the Investigator.
- Additional disabilities that may affect the subject's participation or safety during the clinical investigation.
- Unable or unwilling to comply with all the requirements of the clinical investigation as determined by the Investigator.
- Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device.